We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Brain Cancer
Center of Excellence
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Brain Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Brain Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
pramod kumar julka
Apr 19, 2019
Continue with adjuvant temozolomide
Swapan Kumar Nath
Apr 20, 2019
Chemo radiation with temozolamide followed by adjuvant temozolomide
Anastasya Ryabova
Apr 25, 2019
Chemoradiation with temozolamide followed by adjuvant temozolomide
Rob Hendershot
Apr 26, 2019
Bcnu wafers at surgery. Followed by bcnu post surgery until no signs of progression.
Rob Hendershot
May 03, 2019
He can go on keytruda now as it isn’t a trial but a one-off covered protocol with excellent PFS but it he’d need his first infusion to be done +-5days or at 14-days prior to next resection plus 2 to 3 infusions following in 7-21 days for a following set of infusions post surgery noting nothing outside of a trial now is curative as everything available is palliative PD-1 antibody could be combined with another future immunotherapy like a CAR-T once those off of trialing the future. Which might continue PFS into the later date at this time everyone is simply learning how to simply live and continue on with the cancer.
Rob Hendershot
May 03, 2019
He can go on keytruda now as it isn’t a trial but a one-off covered protocol with excellent PFS but it he’d need his first infusion to be done +-5days or at 14-days prior to next resection plus 2 to 3 infusions following in 7-21 days for a following set of infusions post surgery noting nothing outside of a trial now is curative as everything available is palliative PD-1 antibody could be combined with another future immunotherapy like a CAR-T once those off of trialing the future. Which might continue PFS into the later date at this time everyone is simply learning how to simply live and continue on with the cancer.
Amir Anvari
Aug 23, 2019
chemoradiation with temodar and adjuvant temodar
Apr 23, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Jose
McFaline-Figueroa
MD, PhD
pramod kumar julka
Apr 19, 2019
Swapan Kumar Nath
Apr 20, 2019
Anastasya Ryabova
Apr 25, 2019
Rob Hendershot
Apr 26, 2019
Rob Hendershot
May 03, 2019
Rob Hendershot
May 03, 2019
Amir Anvari
Aug 23, 2019
Apr 23, 2024
Pending Moderator approval.